Longshengzhi Capsules Improve Ischemic Stroke Outcomes and Reperfusion Injury via the Promotion of Anti-Inflammatory and Neuroprotective Effects in MCAO/R Rats
Stroke is the leading cause of death in the elderly. Traditional Chinese medicine provides an exciting strategy for treating stroke. Previous reports indicated that Longshengzhi capsules (LSZ), a modified Chinese formula, reduced formed thrombi and oxidative stress and were promising in the clinical...
Main Authors: | Weinan Yang, Lincheng Zhang, Simiao Chen, Qigu Yao, Haihong Chen, Jing Zhou, Weiyan Chen, Lan He, Yuyan Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2020/9654175 |
Similar Items
-
Neuroprotective effect of Longshengzhi capsule following permanent middle cerebral artery occlusion in rats
by: Xiaoli Sun, et al.
Published: (2020-03-01) -
LongShengZhi capsule inhibits doxorubicin-induced heart failure by anti-oxidative stress
by: Shuai Xu, et al.
Published: (2020-03-01) -
LongShengZhi Capsule Attenuates Alzheimer-Like Pathology in APP/PS1 Double Transgenic Mice by Reducing Neuronal Oxidative Stress and Inflammation
by: Zequn Yin, et al.
Published: (2020-11-01) -
Mechanism underlying sevoflurane-induced protection in cerebral ischemia–reperfusion injury
by: Chen Bing, et al.
Published: (2021-03-01) -
The Neuroprotective Effect of Irisin in Ischemic Stroke
by: Yaqiang Liu, et al.
Published: (2020-12-01)